Robinhood Markets, Inc.’s Black Diamond Therapeutics BDTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$59 Buy
+31
New +$61 ﹤0.01% 1205

Other funds holding BDTX

Robinhood Markets, Inc.'s BDTX Position: Q3 2026 in Review

Robinhood Markets, Inc. opened a new position in Black Diamond Therapeutics (BDTX) in Q3 2026: 31 shares worth $59. The stake represents ﹤0.01% of the portfolio and ranks #1205 among its holdings.

111 funds tracked by Wall St. Rank hold BDTX as of Q3 2026.

  • Robinhood Markets, Inc. held 31 shares of Black Diamond Therapeutics worth $59 as of Q3 2026.
  • Black Diamond Therapeutics was a new Robinhood Markets, Inc. position in Q3 2026.
  • Black Diamond Therapeutics made up ﹤0.01% of Robinhood Markets, Inc.'s portfolio in Q3 2026, its #1205 holding.
  • 111 funds tracked by Wall St. Rank held Black Diamond Therapeutics as of Q3 2026.

Based on Robinhood Markets, Inc.'s 13F filing for Q3 2026, filed 18 Nov 2026.